These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 94625)

  • 21. Electrophysiological and hemodynamic effects of vernakalant and flecainide during cardiac resynchronization in dyssynchronous canine hearts.
    van Middendorp LB; Strik M; Houthuizen P; Kuiper M; Maessen JG; Auricchio A; Prinzen FW
    J Cardiovasc Pharmacol; 2014 Jan; 63(1):25-32. PubMed ID: 24084224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardioprotective effects of various class I antiarrhythmic drugs in canine hearts.
    Hanaki Y; Sugiyama S; Hieda N; Taki K; Hayashi H; Ozawa T
    J Am Coll Cardiol; 1989 Jul; 14(1):219-24. PubMed ID: 2738264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic and regional hemodynamic, antiarrhythmic and antiischemic effects of bevantolol in anesthetized pigs.
    Verdouw PD; Hartog JM; Saxena PR; Hugenholtz PG
    Am J Cardiol; 1986 Nov; 58(12):8E-16E. PubMed ID: 2878601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The electrophysiology and pharmacology of verapamil, flecainide, and amiodarone: correlations with clinical effects and antiarrhythmic actions.
    Singh BN; Nademanee K; Josephson MA; Ikeda N; Venkatesh N; Kannan R
    Ann N Y Acad Sci; 1984; 432():210-35. PubMed ID: 6395762
    [No Abstract]   [Full Text] [Related]  

  • 25. Oral flecainide acetate for the treatment of ventricular arrhythmias.
    Anderson JL; Stewart JR; Perry BA; Van Hamersveld DD; Johnson TA; Conard GJ; Chang SF; Kvam DC; Pitt B
    N Engl J Med; 1981 Aug; 305(9):473-7. PubMed ID: 7019711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of a new antiarrhythmic agent, flecainide acetate, on systolic time intervals.
    Muhiddin KA; Shaw E; Blackett A; Patel L; Turner P
    Eur J Clin Pharmacol; 1983; 25(1):13-8. PubMed ID: 6617715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A proposal for the clinical use of flecainide.
    Anderson JL; Stewart JR; Crevey BJ
    Am J Cardiol; 1984 Feb; 53(5):112B-119B. PubMed ID: 6364767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of flecainide on ventricular function: clinical and experimental correlations.
    Josephson MA; Ikeda N; Singh BN
    Am J Cardiol; 1984 Feb; 53(5):95B-100B. PubMed ID: 6695822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of electrophysiologic and hemodynamic effects of SD-3212, a new antiarrhythmic drug, and flecainide in a canine myocardial infarction model.
    Hashimoto H; Umemura K; Araki S; Ishii M; Nagashima S; Uematsu T; Nakashima M
    Biol Pharm Bull; 1994 Apr; 17(4):548-50. PubMed ID: 8069268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemodynamic dose-response effects of flecainide in acute myocardial infarction with and without left ventricular decompensation.
    Jackson N; Verma SP; Frais MA; Silke B; Hafizullah M; Reynolds G; Taylor SH
    Clin Pharmacol Ther; 1985 Jun; 37(6):619-24. PubMed ID: 3891187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracoronary infusion of Gd3+ into ischemic region does not suppress phase Ib ventricular arrhythmias after coronary occlusion in swine.
    Barrabés JA; Garcia-Dorado D; Agulló L; Rodríguez-Sinovas A; Padilla F; Trobo L; Soler-Soler J
    Am J Physiol Heart Circ Physiol; 2006 Jun; 290(6):H2344-50. PubMed ID: 16387793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disappearance with ischaemic depolarization of the antifibrillatory activity in a sodium channel blocker and appearance in calcium channel blocker.
    Bui-Xuan B; Aupetit JF; Freysz M; Loufoua-Moundanga J; Faucon G; Timour Q
    Arch Int Pharmacodyn Ther; 1996; 331(3):246-62. PubMed ID: 9124997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimizing flecainide plasma concentration profile for atrial fibrillation conversion while minimizing adverse ventricular effects by rapid, low-dose intratracheal or intravenous administration.
    Marum AA; Silva BA; Bortolotto AL; Silva AC; de Antonio VZ; Belardinelli L; Verrier RL
    Int J Cardiol; 2019 Jan; 274():170-174. PubMed ID: 30217428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of an anesthetized dog model of transient cardiac ischemia and rapid pacing: a pilot study for preclinical assessment of the potential for proarrhythmic risk of novel drug candidates.
    Damiano BP; van der Linde HJ; Van Deuren B; Somers Y; Lubomirski M; Teisman A; Gallacher DJ
    J Pharmacol Toxicol Methods; 2015; 72():72-84. PubMed ID: 25450838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiarrhythmic, electrophysiologic and hemodynamic effects of ACC-9358.
    Brown BS; Calzadilla SV; Diemer MJ; Hartman JC; Reynolds RD
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1225-34. PubMed ID: 3694532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electrophysiological effects of a new antiarrhythmic agent, flecainide, on the intact canine heart.
    Hodess AB; Follansbee WP; Spear JF; Moore EN
    J Cardiovasc Pharmacol; 1979; 1(4):427-39. PubMed ID: 94620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resolution of flecainide acetate, N-(2-piperidylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzam ide acetate, and antiarrhythmic properties of the enantiomers.
    Banitt EH; Schmid JR; Newmark RA
    J Med Chem; 1986 Feb; 29(2):299-302. PubMed ID: 3950909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flecainide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy.
    Holmes B; Heel RC
    Drugs; 1985 Jan; 29(1):1-33. PubMed ID: 3882390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A double-blind, crossover comparison of flecainide acetate and disopyramide phosphate in the treatment of ventricular premature complexes.
    Kjekshus J; Bathen J; Orning OM; Storstein L
    Am J Cardiol; 1984 Feb; 53(5):72B-78B. PubMed ID: 6421140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of anipamil, a long acting analog of verapamil, in pigs subjected to myocardial ischemia.
    Pugsley MK; Ries CR; Guppy LJ; Harvie CJ; Walker MJ
    Life Sci; 1995; 57(12):1219-31. PubMed ID: 7674811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.